Cargando…
More light on cancer and COVID-19 reciprocal interaction
Cancer patients are vulnerable to COVID-19 with consequences on treatment delays and on mortality rate. This Comment explores the interaction between COVID-19 and cancer with attention paid to the modulation by cancer treatments of both ADAM17 and TMPRSS2, the proteases which control ACE2 processing...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039039/ https://www.ncbi.nlm.nih.gov/pubmed/33531686 http://dx.doi.org/10.1038/s41416-020-01246-0 |
_version_ | 1783677507845750784 |
---|---|
author | Brest, Patrick Mograbi, Baharia Hofman, Paul Milano, Gerard |
author_facet | Brest, Patrick Mograbi, Baharia Hofman, Paul Milano, Gerard |
author_sort | Brest, Patrick |
collection | PubMed |
description | Cancer patients are vulnerable to COVID-19 with consequences on treatment delays and on mortality rate. This Comment explores the interaction between COVID-19 and cancer with attention paid to the modulation by cancer treatments of both ADAM17 and TMPRSS2, the proteases which control ACE2 processing, the SARS-CoV-2 target. |
format | Online Article Text |
id | pubmed-8039039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80390392022-02-03 More light on cancer and COVID-19 reciprocal interaction Brest, Patrick Mograbi, Baharia Hofman, Paul Milano, Gerard Br J Cancer Comment Cancer patients are vulnerable to COVID-19 with consequences on treatment delays and on mortality rate. This Comment explores the interaction between COVID-19 and cancer with attention paid to the modulation by cancer treatments of both ADAM17 and TMPRSS2, the proteases which control ACE2 processing, the SARS-CoV-2 target. Nature Publishing Group UK 2021-02-03 2021-04-12 /pmc/articles/PMC8039039/ /pubmed/33531686 http://dx.doi.org/10.1038/s41416-020-01246-0 Text en © The Author(s), under exclusive licence to Cancer Research UK 2021 https://creativecommons.org/licenses/by/4.0/Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0). |
spellingShingle | Comment Brest, Patrick Mograbi, Baharia Hofman, Paul Milano, Gerard More light on cancer and COVID-19 reciprocal interaction |
title | More light on cancer and COVID-19 reciprocal interaction |
title_full | More light on cancer and COVID-19 reciprocal interaction |
title_fullStr | More light on cancer and COVID-19 reciprocal interaction |
title_full_unstemmed | More light on cancer and COVID-19 reciprocal interaction |
title_short | More light on cancer and COVID-19 reciprocal interaction |
title_sort | more light on cancer and covid-19 reciprocal interaction |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039039/ https://www.ncbi.nlm.nih.gov/pubmed/33531686 http://dx.doi.org/10.1038/s41416-020-01246-0 |
work_keys_str_mv | AT brestpatrick morelightoncancerandcovid19reciprocalinteraction AT mograbibaharia morelightoncancerandcovid19reciprocalinteraction AT hofmanpaul morelightoncancerandcovid19reciprocalinteraction AT milanogerard morelightoncancerandcovid19reciprocalinteraction |